CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Oct. 01, 2023	Oct. 02, 2022
Cash flows from operating activities
Net loss	$ (6,820)	$ (27,868)
Adjustments to reconcile net loss to net cash used in operating activities:
Impairment and other charges	9,548	4,678
Depreciation and amortization	60,114	66,345
Gain on remeasurement of warrant liability	(16,560)	(4,032)
Loss (gain) on sale of assets	9,275	(919)
Share-based compensation	11,808	7,579
Deferred taxes	(10,743)	(1,315)
Deferred financing costs	1,084	1,047
Changes in assets and liabilities:
Accounts receivable, net	4,947	(12,628)
Inventories	644	(27,866)
Prepaid expenses and other assets	(20,183)	(18,308)
Accounts payable and accrued expenses and other	6,016	21,358
Net cash provided by operating activities	49,130	8,071
Cash flows from investing activities
Acquisitions, net of cash acquired	0	(75)
Purchases of property and equipment	(45,707)	(68,708)
Proceeds from sale of property and equipment	8,794	4,100
Proceeds from sale of routes	21,683	16,819
Proceeds from the sale of IO notes	4,094	5,017
Proceeds from insurance claims for capital investments	0	3,935
Notes receivable, net	(26,369)	(14,028)
Net cash used in investing activities	(37,505)	(52,940)
Cash flows from financing activities
Line of credit borrowings, net	20,324	40,390
Borrowings on term debt and notes payable	4,273	33,969
Repayments on term debt and notes payable	(23,744)	(20,692)
Payment of debt issuance cost	(655)	(1,471)
Payments of tax withholding requirements for employee stock awards	(589)	(6,217)
Proceeds from issuance of shares	0	28,000
Dividends	(13,921)	(12,793)
Distribution to noncontrolling interest	(10,149)	(6,410)
Net cash (used in) provided by financing activities	(24,461)	54,776
Net (decrease) increase in cash and cash equivalents	(12,836)	9,907
Cash and cash equivalents at beginning of period	72,930	41,898
Cash and cash equivalents at end of period	$ 60,094	$ 51,805